Clinical Trial Update: Consistency of 3 Consecutive Lots of a Novel HBV Vaccine With Single-blind Safety Evaluation Using Engerix™-B as Control [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the manufacturing consistency of three consecutive lots of a novel hepatitis B vaccine, using Engerix-B as a control in a single-blind s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Engerix-B (hepatitis B vaccine)
• HBV vaccine (novel)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 3 | Status: COMPLETED